Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  MetLife    MET

METLIFE (MET)

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Metlife Inc : MetLife Posts Wider 1Q Loss Than Projected On Larger Investment Losses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/27/2012 | 04:08am CEST

("MetLife Posts Wider 1Q Loss Than Projected On Smaller Tax Benefit," published at 4:59 p.m. EDT, and a correction at 5:38 p.m. misstated the reason for MetLife's wider loss. The correct version follows:)

MetLife Inc. (MET) reported a wider first-quarter loss than it projected last week as the life insurer posted larger net investment losses.

Last Friday, the biggest U.S. insurer reported preliminary results after inadvertently posting some of its financial data on its website ahead of the scheduled release.

The company posted a loss of $144 million, or 16 cents a share, widening from the $64 million it estimated last week and compared with the year-earlier profit of $877 million. It posted net investment losses of $110 million, versus the $30 million projected last week.

Operating earnings, which exclude investment gains and losses, came in at $1.37 a share, as reported last Friday. Operating revenue, which likewise strips out some investment effects, also was unchanged at $16.69 billion, up 6.9%.

The bottom-line result was driven by net derivative losses of $1.98 billion, while the year-earlier period's loss was a mere $315 million. Like its fellow insurers, MetLife uses derivatives to hedge a number of risks, including changes in interest rates and fluctuations in foreign currencies.

MetLife said earlier Thursday it is selling its reverse-mortgage business, its latest move to avoid increased regulatory scrutiny and stay focused on its core operations.

In March, it failed "stress tests" by the Federal Reserve that were aimed at gauging the capital adequacy of 19 of the biggest U.S. financial firms under a severe economic worsening.

MetLife shares closed Thursday at $36.47 and were inactive after hours. The stock is up 17% so far this year.

-By Lauren Pollock, Dow Jones Newswires; 212-416-2356; [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on METLIFE
06/22 METLIFE INC : Creation of a Direct Financial Obligation or an Obligation under a..
06/22 METLIFE : Names New Chief Human Resources Officer
06/22 METLIFE HONG KONG : Surges Ahead with Triple-digit Business Growth in the First ..
06/21 METLIFE : Releases Annual Corporate Responsibility Report
06/21 METLIFE : Sanjeev Kapur Joins MetLife as Chief Marketing Officer for Asia
06/20 METLIFE : Sanjeev Kapur Joins MetLife as Chief Marketing Officer for Asia
06/15 METLIFE INC : Submission of Matters to a Vote of Security Holders (form 8-K)
06/15DJMETLIFE : Promotes Two Senior Executives as Future CEO Succession Race Takes Sha..
06/15 METLIFE : Announces Senior Leadership Changes
06/12 METLIFE : Names New Chief Human Resources Officer
More news
Sector news : Life & Health Insurance - NEC
06/22 ABERDEEN ASSET MANAGEMENT : UK competition watchdog clears Standard Life-Aberdee..
06/16 Supermarket stocks go stale on FTSE after tumultuous week
06/16 NOT YET AMAZON PRIME TIME : Australia retail sell-off overblown?
06/15 Personal injury rate change to cost British motor insurers 3.5 billion pounds..
06/14 Shareholder adviser says Petropavlovsk's Peter Hambro should go
More sector news : Life & Health Insurance - NEC
News from SeekingAlpha
06/22 MetLife accounting exaggerates profitability - Citi
06/15 MetLife builds bench for possible CEO succession
06/11 Strong Dividend Yields Via Dividend Champions
06/09 Insurance Is Gambling. Seriously.
06/08 After beating U.S. in court, MetLife general counsel exiting
Advertisement
Financials ($)
Sales 2017 68 677 M
EBIT 2017 7 128 M
Net income 2017 5 632 M
Debt 2017 -
Yield 2017 3,10%
P/E ratio 2017 10,65
P/E ratio 2018 9,24
Capi. / Sales 2017 0,82x
Capi. / Sales 2018 0,80x
Capitalization 56 228 M
More Financials
Chart METLIFE
Duration : Period :
MetLife Technical Analysis Chart | MET | US59156R1086 | 4-Traders
Full-screen chart
Technical analysis trends METLIFE
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 59,4 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Steven Albert Kandarian Chairman, President & Chief Executive Officer
Martin J. Lippert Executive VP-Global Technology & Operations
John C. R. Hele Chief Financial Officer & Executive Vice President
Jacki Goldstein Chief Medical Officer
Cheryl W. Grisé Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
METLIFE-3.02%56 228
AXA-0.27%64 935
PRUDENTIAL10.41%59 084
PRUDENTIAL FINANCIAL I..-0.72%44 483
MANULIFE FINANCIAL COR..-2.60%35 206
AFLAC INCORPORATED11.49%30 795
More Results